Evaluation of pharmacological potentials of the aerial part of Achyranthes aspera L.: in vivo, in vitro and in silico approaches

다국어 초록 (Multilingual Abstract)

Achyranthes aspera L. (Prickly Chaff flower) is an imperative Asian herb that has been known for numerous healing powers.
The aim of this research is to investigate the pharmacological i.e., antidepressant and anxiolytic properties of the methanol extract of aerial part of A. aspera (MEAA) by in vivo and in silico approaches. Additionally, thrombolytic potential of the crude extract has also been explored. The antidepressant and anxiolytic investigations were performed by force swimming test (FST), tail suspension test (TST), and hole board test (HBT) in mice, whereas clot lysis activity test was conducted using thrombolytic experimental method. Furthermore, in silico studies were appraised with Discovery studio, PyRx, UCSF Chimera whereas, PASS prediction, and ADME/T was implemented using online tools. Treatment with MEAA revealed significant (p < 0.05) reduction of immobility time in FST and TST, increased head dipping and decreased the latency of time in HBT. Besides, MEAA produced significant (p < 0.001) clot lysis activity at a minimum dose. In the computer-aided approach, among all the proteins, the docking score has been revealed ranging from − 2.31 kcal/mol to − 7.4 kcal/mol.
Spathulenol, diazepam and hydroquinone showed the best binding affinity and all compounds were found safe in ADME/T study. The outcomes of this research demonstrate that MEAA may provide potential for mitigating depression, anxiety, and coagulation.

참고문헌 (Reference)

1 Cheng F, "admetSAR : a comprehensive source and free tool for assessment of chemical ADMET properties" ACS Publications 2012

2 Coleman JA, "X-ray structures and mechanism of the human serotonin transporter" 532 : 334-339, 2016

3 Fajemiroye JO, "Treatment of anxiety and depression : medicinal plants in retrospect" 30 : 198-215, 2016

4 Haque MA, "Tinospora species : An overview of their modulating effects on the immune system" 207 : 67-85, 2017

5 Haines ST, "Thrombosis and the pharmacology of antithrombotic agents" 29 : 892-905, 1995

6 Yuan J, "Thrombolytic effects of Douchi fibrinolytic enzyme from Bacillus subtilis LD-8547 in vitro and in vivo" 12 : 36-, 2012

7 Möller H-J, "The relevance of ‘mixed anxiety and depression’as a diagnostic category in clinical practice" 266 : 725-736, 2016

8 Wang S, "Synthesis and evaluation of antidepressant activities of 5-aryl-4, 5-dihydrotetrazolo [1, 5-a] thieno [2, 3-e] pyridine derivatives" 24 : 1857-, 2019

9 Ali MS, "Study of sedative activity of different extracts of Kaempferia galanga in Swiss albino mice" 15 : 158-, 2015

10 Lenaeus MJ, "Structures of KcsA in complex with symmetrical quaternary ammonium compounds reveal a hydrophobic binding site" 53 : 5365-5373, 2014

11 Renatus M, "Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitors" 272 : 21713-21719, 1997

12 Haque MA, "Standardized extract of Zingiber zerumbet suppresses LPS-induced pro-inflammatory responses through NF-κB, MAPK and PI3K-Akt signaling pathways in U937 macrophages" 54 : 195-205, 2019

13 Guedes IA, "Receptor–ligand molecular docking" 6 : 75-87, 2014

14 Parasuraman S, "Prediction of activity spectra for substances" 2 : 52-, 2011

15 Tatarczyńska E, "Potential anxiolytic-and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist" 132 : 1423-1430, 2001

16 Khan S, "Phytochemical profiling, in vitro biological properties and in silico studies on Caragana ambigua stocks(Fabaceae) : a comprehensive approach" 131 : 117-124, 2019

17 Bhoomika R, "Phyto-pharmacology of Achyranthes aspera : a review" 1 : 143-, 2007

18 Goel RK, "PASS-assisted exploration of new therapeutic potential of natural products" 20 : 1509-1514, 2011

19 Khurana N, "PASS assisted prediction and pharmacological evaluation of novel nicotinic analogs for nootropic activity in mice" 662 : 22-30, 2011

20 Poroikov V, "PASS : prediction of biological activity spectra for substances" 520 : 520-, 2005

21 Depression W, "Other common mental disorders: global health estimates"

22 Mojumdar M, "Molecular docking and pass prediction for analgesic activity of some isolated compounds from Acalypha indica L. and ADME/T property analysis of the compounds" 5 : 1761-1770, 2016

23 Herowati R, "Molecular Docking studies of chemical constituents of Tinospora cordifolia on glycogen phosphorylase" 13 : 63-68, 2014

24 Kara S, "Mixed anxiety–depressive disorder and major depressive disorder : comparison of the severity of illness and biological variables" 94 : 59-66, 2000

25 Lipinski CA, "Lead-and drug-like compounds : the rule-of-five revolution" 1 : 337-341, 2004

26 Borsini F, "Is the forced swimming test a suitable model for revealing antidepressant activity?" 94 : 147-160, 1988

27 Nazim Uddin Emon ; Israt Jahan ; Mohammed Aktar Sayeed, "Investigation of antinociceptive, anti-inflammatory and thrombolytic activity of Caesalpinia digyna (Rottl.) leaves by experimental and computational approaches" 융합한의과학연구소 20 (20): 451-459, 2020

28 Viran R, "Investigation of acute toxicity of deltamethrin on guppies(Poecilia reticulata)" 55 : 82-85, 2003

29 Schechter LE, "Innovative approaches for the development of antidepressant drugs : current and future strategies" 2 : 590-611, 2005

30 Haque MA, "Exploring the immunomodulatory and anticancer properties of zerumbone" 8 : 3410-3431, 2017

31 Lipinski CA, "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings" 23 : 3-25, 1997

32 Moniruzzaman M, "Evaluation of sedative and hypnotic activity of ethanolic extract of Scoparia dulcis Linn" 2015 : 873954-, 2015

33 Jain S, "Ethnomedicinal plants of Jaunsar-Bawar Hills, Uttar Pradesh, India" 12 : 213-222, 1984

34 Prasad S, "Effect of Fagonia arabica(Dhamasa)on in vitro thrombolysis" 7 : 36-, 2007

35 Zhang M-Q, "Drug discovery beyond the ‘rule-offive’" 18 : 478-488, 2007

36 Willner P, "Dopamine and depression : a review of recent evidence. I. Empirical studies" 6 : 211-224, 1983

37 Biovia DS, "Discovery studio visualizer"

38 Prasad S, "Development of an in vitro model to study clot lysis activity of thrombolytic drugs" 4 : 14-, 2006

39 Goodwin FK, "Depressions following reserpine:a reevaluation" Grune & Stratton, Inc 1971

40 Gold PW, "Clinical and biochemical manifestations of depression" 319 : 413-420, 1988

41 Takeda H, "Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice" 350 : 21-29, 1998

42 Sajib Rudra M, "Biological investigations of the methanol extract of Tetrastigma leucostaphylum (Dennst.) Alston ex Mabb.(Vitaceae): in vivo and in vitro approach"

43 Porsolt R, "Behavioral despair in mice : a primary screening test for antidepressants" 229 : 327-336, 1977

44 Hassan W, "Association of oxidative stress to the genesis of anxiety : implications for possible therapeutic interventions" 12 : 120-139, 2014

45 Cryan JF, "Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test" 29 : 547-569, 2005

46 Emon NU, "Anxiolytic and thrombolytic investigation of methanol extract of Piper nigrum L. fruits and Sesamum indicum L. seeds" 3 : 158-164, 2020

47 Scott IM, "Analysis of Piperaceae germplasm by HPLC and LCMS : a method for isolating and identifying unsaturated amides from Piper spp extracts" 53 : 1907-1913, 2005

48 Shapovalov MV, "A smoothed backbonedependent rotamer library for proteins derived from adaptive kernel density estimates and regressions" 19 : 844-858, 2011